首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1336661

全球生物可吸收聚合物市场 - 2023-2030

Global Bioresorbable Polymers Market - 2023-2030

出版日期: 2023年08月22日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球生物可吸收聚合物市场将于 2022 年达到 12 亿美元，预计到 2030 年将达到 33 亿美元，2023-2030 年预测期间年复合成长率为 13.4%。

生物可吸收聚合物市场的显着增长归因于汽车、医疗保健和包装等各个行业的需求不断增长。它在医疗器械方面具有多种优势，因此生物可吸收聚合物市场需求增加。生物可吸收市场增长的关键因素之一是它提供与人体相容的材料，从而降低感染风险。

亚太地区的生物可吸收聚合物市场增长显着，中国、日本和印度等国家也出现大幅增长。在不断增长的医疗保健需求、支持性的监管环境和强大的製造生态系统等因素的推动下，该地区见证了生物可吸收聚合物的巨大增长机会。

例如，2021 年 4 月 21 日，加州大学伯克利分校的科学家发明了一种解决方案，可以在热和水的帮助下轻鬆分解可堆肥塑料。这些解决方案适用于其他类型的聚酯塑料。该解决方案还包括受聚合物保护的酶，但当这些酶暴露于热和水时，塑料聚合物会分解成构成成分。

市场动态

生物可吸收聚合物在骨科手术中的进展和应用

由于其独特的潜在应用，生物可吸收聚合物在医疗领域见证了显着增长。生物可吸收聚合物在骨科手术中有多种应用，包括骨折固定和骨组织再生。在生物可吸收聚合物的帮助下，它消除了手术和感染的需要。它们暂时固定骨折的骨头，并在骨头开始癒合时逐渐降解。

医疗技术领域不断发展，例如2021年2月1日，3D生物可吸收CMF板上市。由于生物可吸收聚合物具有足够的强度，它取代了传统的金属材料装置。名为 L-丙交酯和己内酯的生物可吸收聚合物与熔丝系统的组合。例如，2021 年 12 月 8 日，BMF 和 4D 生物材料宣布推出首款 4Degra 生物可吸收材料，该材料可在体内降解。这些材料解决了设计和生物相容性问题。

环境问题和可持续包装需求

由于环境因素的增加和对可持续包装解决方案的需求不断增加，生物可吸收聚合物见证了包装行业的最高增长。生物可吸收聚合物也称为可生物降解聚合物，其中材料自然分解。随着消费者转向可生物降解的塑料，与传统塑料相比，这种塑料造成的污染更少，这是推动包装行业生物可吸收聚合物增长的关键因素之一。

各种合作是减少一次性塑料和促进可持续包装的重要一步，例如，2021 年6 月16 日，Mint 发表新闻称，DRDO 与Acharya Nagarjuna 大学和Ecolastic 私人有限公司合作推出了一种由植物製成的可生物降解包装产品，基于食品级和天然材料，是一种天然安全的产品，不会危害环境。该产品的目的是减少一次性塑料的使用。这些塑料袋具有成本效益、可持续且对海洋安全。

生产成本高

高生产成本是生物可吸收聚合物市场的一个主要因素。许多公司发现很难投资生物可吸收聚合物，因为该产品的生产需要很大的製造规模。此外，使用可再生原料会导致更高的成本。生物可吸收聚合物的较高成本阻碍了生物可吸收聚合物在许多行业的增长。

消费者的接受度对于生物可吸收聚合物在市场上的采用起着非常重要的作用。这种生物可吸收聚合物的增长取决于消费者对其应用和优点的了解。在与该市场相关的消费者之间建立信任对其增长至关重要。为了这个市场的增长和知名度，需要具有成本效益的社交媒体、网站和包装标籤。

COVID-19 影响分析

在 COVID-19 的早期阶段，生物可吸收聚合物市场面临混乱。受疫情影响，许多生产设施暂时关闭和延误。医疗保健部门正在减少非必要的医疗程序。这影响了对基于生物可吸收聚合物的医疗器械的需求。

COVID-19 大流行措施主要侧重于药物输送系统。对于疫苗和治疗，可以利用生物可吸收聚合物。这增加了对药物递送系统（包括微粒、纳米颗粒和支架）的需求。生物可吸收聚合物在组织工程支架中发挥着至关重要的作用，为细胞生长和组织再生提供临时支持。

俄罗斯-乌克兰战争影响

俄罗斯-乌克兰战争影响生物可吸收聚合物的供应链。运输路线中断，製造设施受到影响。它导致生产和分销的延误。这种衝突造成了经济和政治不稳定的环境。

俄罗斯和乌克兰以及与其他捲入战争的国家之间的贸易关係受到影响。贸易壁垒、出口限製或进出口法规的变化扰乱了生物可吸收聚合物的流动。这会影响国际贸易，并可能限制製造商和供应商的市场准入。在战争期间，医疗保健资源经常被重新分配以解决紧急医疗需求。

Market Overview

The Global Bioresorbable Polymers Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 3.3 billion by 2030 growing with a CAGR of 13.4% during the forecast period 2023-2030.

The significant growth in the bioresorbable polymer market is due to increasing demand from various sectors named as automotive, healthcare and packaging. It offers several advantages in medical appliances due to which the bioresorbable polymer market demand increases. One of the key factors where the bioresorbable market is growing is that it offers materials that are compatible with the human body which reduces the risk of infections.

Asia-Pacific emerged with prominent growth in the bioresorbable polymer market and there is substantial growth in countries like China, Japan and India. The region witnessed significant growth opportunities for bioresorbable polymers, driven by factors such as increasing healthcare demand, a supportive regulatory environment and a robust manufacturing ecosystem.

For instance, on 21 April 2021, scientists from the University of California, Berkeley invented a solution that breaks compostable plastics easily with the help of heat and water. These solutions apply to other types of polyester plastics. This solution also includes enzymes that are protected by polymers but when these enzymes are exposed to heat and water then plastic polymer breaks into constitute components.

Market Dynamics

Advancements and Applications of Bioresorbable Polymers in Orthopedic Surgeries

Bioresorbable polymers witnessed significant growth in the medical field due to their unique potential applications. Bioresorbable polymers found various applications in orthopedic surgeries that include fracture fixations and bone tissue regeneration. With the help of bioresorbable polymer, it eliminates the need for surgery and infections. They temporarily fix the fractured bones and degrade gradually when bones start healing.

The field of medical technology witnessed development, For instance, on 1 Feb 2021, 3D bioresorbable CMF plates were launched. Due to the sufficient strength of the bioresorbable polymer, it replaces traditional devices with metallic materials. Bioresorbable polymers named L-lactide and caprolactone with a combination of fuse filament systems. For instance, on 8 Dec 2021, BMF and 4D biomaterials announce the first 4Degra bioresorbable materials this material degrades in the body. These materials solve design and biocompatibility issues.

Environmental Concerns and Sustainable Packaging Demand

Bioresorbable polymers witnessed the highest growth in the packaging industry due to an increase in environmental factors and increasing demand for sustainable packaging solutions. The bioresorbable polymer also called biodegradable polymer in which materials naturally break down. One of the key factors that drives the growth of bioresorbable polymers in the packaging industry as consumers are moving towards biodegradable plastics which cause less pollution compared to traditional plastics.

A significant step towards reducing single-use plastics and promoting sustainable packaging there is various collaborations, For instance, on 16 Jun 2021, news published in Mint that DRDO collaboration with Acharya Nagarjuna University and Ecolastic private limited launched a biodegradable packaging product made from plant-based food grade and natural materials which is a naturally safe product that doesn't harm the environment. The product has the aim of reducing single-use plastics. These plastic bags are cost-effective, sustainable and ocean-safe.

High Production Cost

High production cost is a major factor for this bioresorbable polymer market. Many companies find it difficult to invest in bioresorbable polymers because the production of this product requires a large manufacturing scale. Additionally, the usage of renewable feedstocks leads to higher costs. The higher cost of bioresorbable polymers hinders the growth of bioresorbable in many industries.

Consumer acceptance plays a very important role in the adoption of bioresorbable polymers in the market. The growth of this bioresorbable polymer depends on consumers' understanding of its applications and benefits. Building trust among consumers related to this market is very crucial for its growth. For the growth and awareness of this market, it requires social media, websites and packaging labels which are cost-effective.

COVID-19 Impact Analysis

In the early stages of COVID-19 bioresorbable polymer market faces disruptions. Due to the pandemic, many manufacturing facilities are temporarily shut down and delayed. The healthcare sector dealing with a decrease in non-essential medical procedures. This impacts the demand for bioresorbable polymer-based medical devices.

COVID-19 pandemic measures focus mainly on drug delivery systems. For vaccines and therapy, bioresorbable polymers can be utilized. This increases the demand for drug delivery systems including microparticles, nanoparticles and scaffolds. Bioresorbable polymers play a crucial role in tissue engineering scaffolds, providing temporary support for cell growth and tissue regeneration.

Russia-Ukraine War Impact

Russia-Ukraine war impacts supply chains of bioresorbable polymers. There are disruptions in transportation routes and manufacturing facilities are affected. It leads to delays in production and distribution. This conflict causes an environment of economic and political instability.

Trade relations between Russia and Ukraine, as well as with other countries involved in the war are affected. Trade barriers, export restrictions, or changes in import and export regulations disrupt the flow of bioresorbable polymers. This impacts international trade and potentially limits market access for manufacturers and suppliers. During the war, healthcare resources are often redirected to address urgent medical needs.

Segment Analysis

The global bioresorbable polymers are segmented based on type, application and region.

Polymer-Based Drug Delivery Systems

There is a significant advancement in the field of drug delivery systems which has made bioresorbable polymers grow in the segment, leading it to cover nearly 35.5% globally. Bioresorbable polymers provide a platform that controls drug delivery systems. This polymer's material is designed to degrade the body over time and eliminates surgical complications. These polymers are biocompatible which means they are well-adaptable by the body and don't release any toxicity.

Scientists growing significant breakthroughs for ocular drug delivery systems, For instance on 18 April 2023, a report by MCDOUGALL Communications in which a scientist from the Center for Ocular Research and Education fabricated a microfluid chip that evaluates the contact lens-based drug release. For better-evaluating drug delivery, scientists designed a soft hydrogel eyes model that includes the upper and lower eyelid. The eyeball and lower eyelid were 3D bio printed which breakthroughs the ocular drug delivery system.

Geographical Penetration

Asia-Pacific Government's Initiatives and Innovations Driving Sustainable Solutions

Asia-Pacific has significant growth in the bioresorbable market and government support has made the region cover more than 58.4% in the forecast period. As growing population plastic pollution also increases in countries named India, China and Singapore government has taken various initiatives to reduce plastic waste.

News by Biospectrum Asia edition, there is a collaboration between Osterpore International and the national university of Singapore startup, For instance, on 11 Dec 2020 named Magloy Tech launched its first fully degradable facial bone fixation solution which consists of magnesium plates and screws. The bioresorbable polymer bone implant dissolves in carbon dioxide and water. This solution leaves zero residues after the wound is cured.

Competitive Landscape

The major global players in the market include: Ashland Global Holdings Inc, Corbion N.V, Evonik Industries AG, Poly-Med Inc, KLS Martin Group, Foster Corporation, Zeus Industrial Products, Seqens Group, REVA Medical, LLC, Nomisma Healthcare Pvt. Ltd.

Why Purchase the Report?

To visualize the global bioresorbable polymers market segmentation based segmented based on type, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of bioresorbable polymers market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Application mapping available as excel consisting of key application of all the major players.

The global bioresorbable polymers market report would provide approximately 53 tables, 49 figures and195 Pages

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet By Type
3.2. Snippet By Application
3.3. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Demand for Biocompatible Medical Devices
  - 4.1.1.2. Environmental Concerns and Sustainable Packaging Demand
  - 4.1.1.3. Advancements and Applications of Bioresorbable Polymers in Orthopedic Surgeries
- 4.1.2. Restraints
  - 4.1.2.1. High Production Cost
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Polylactic Acid (PLA) *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polyglycolic Acid (PGA)
7.4. Poly (lactic-co-glycolic acid) (PLGA)
7.5. Polycaprolactone (PCL)
7.6. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Orthopedic Devices*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Drug Delivery
8.4. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.5.1. Germany
  - 9.3.5.2. UK
  - 9.3.5.3. France
  - 9.3.5.4. Italy
  - 9.3.5.5. Russia
  - 9.3.5.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.5.1. Brazil
  - 9.4.5.2. Argentina
  - 9.4.5.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis s

11. Company Profiles

11.1. Ashland Global Holdings Inc *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Corbion N.V
11.3. Evonik Industries AG
11.4. Poly-Med Inc
11.5. KLS Martin Group
11.6. Foster Corporation
11.7. Zeus Industrial Products
11.8. Seqens Group
11.9. REVA Medical, LLC
11.10. Nomisma Healthcare Pvt. Ltd

LIST NOT EXHAUSTIVE